DOW:NYE-Dow Inc (USD)

COMMON STOCK | Chemicals |

Last Closing

USD 28.18

Change

-0.10 (-0.35)%

Market Cap

N/A

Volume

8.63M

Analyst Target

USD 46.65
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-05 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap
HUN Huntsman Corporation

-0.19 (-1.65%)

USD 1.94B
BAK Braskem SA Class A

-0.01 (-0.27%)

USD 1.44B
WLKP Westlake Chemical Partners LP

-0.01 (-0.05%)

USD 0.79B
TROX Tronox Holdings PLC

+0.02 (+0.35%)

USD 0.75B
ASIX AdvanSix Inc

-0.17 (-0.72%)

USD 0.62B
VHI Valhi Inc

-0.08 (-0.54%)

USD 0.43B
RYAM Rayonier Advanced Materials

N/A

USD 0.26B
LXU Lsb Industries Inc

-0.14 (-1.77%)

N/A
CE Celanese Corporation

-0.15 (-0.27%)

N/A
REX REX American Resources Corpora..

-0.29 (-0.67%)

N/A

ETFs Containing DOW

NDIV Amplify ETF Trust - Ampli.. 4.84 % 0.00 %

-0.01 (1.43%)

USD 0.01B
WMTS:SW iShares MSCI World Materi.. 3.77 % 0.00 %

N/A

USD 0.03B
2B7B:F iShares S&P 500 Materials.. 3.73 % 0.00 %

+0.12 (+1.43%)

N/A
ZWH.U:CA 3.63 % 0.72 %

N/A

N/A
HDCH:SW Invesco S&P 500 High Divi.. 2.46 % 0.00 %

-0.26 (1.43%)

USD 4.28M
DJD Invesco Dow Jones Industr.. 0.00 % 0.09 %

-0.20 (1.43%)

N/A
FMAT Fidelity® MSCI Materials.. 0.00 % 0.08 %

-0.16 (1.43%)

N/A
JHMA 0.00 % 0.47 %

N/A

N/A
FCUD:CA Fidelity U.S. High Divide.. 0.00 % 0.39 %

-0.01 (1.43%)

CAD 0.30B
XLSY 0.00 % 0.00 %

N/A

N/A
BASE:CA Evolve Global Materials &.. 0.00 % 0.00 %

+0.09 (+1.43%)

CAD 0.05B
BASE-B:CA Evolve Global Materials &.. 0.00 % 0.00 %

+0.02 (+1.43%)

CAD 0.08B
SBM 0.00 % 0.95 %

N/A

N/A
SMN ProShares UltraShort Basi.. 0.00 % 0.95 %

+0.20 (+1.43%)

N/A
UYM ProShares Ultra Basic Mat.. 0.00 % 0.95 %

-0.30 (1.43%)

N/A
VAW Vanguard Materials Index .. 0.00 % 0.10 %

-0.52 (1.43%)

N/A
IMSU:LSE iShares S&P 500 Materials.. 0.00 % 0.00 %

-1.50 (1.43%)

N/A
SXLB:LSE SPDR S&P U.S. Materials S.. 0.00 % 0.00 %

-0.02 (1.43%)

N/A
DX2Z:XETRA Xtrackers - S&P Select Fr.. 0.00 % 0.00 %

-0.03 (1.43%)

USD 0.10B
GBDV 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -29.78% 45% F 6% D-
Dividend Return 3.49% 83% B 89% A-
Total Return -26.29% 45% F 7% C-
Trailing 12 Months  
Capital Gain -49.39% 36% F 4% F
Dividend Return 5.03% 86% B+ 74% C
Total Return -44.36% 45% F 4% F
Trailing 5 Years  
Capital Gain -35.91% 36% F 12% F
Dividend Return 31.84% 86% B+ 79% B-
Total Return -4.07% 45% F 19% F
Average Annual (5 Year Horizon)  
Capital Gain -5.11% 15% F 15% F
Dividend Return -0.25% 23% F 23% F
Total Return 4.86% 80% B- 80% B-
Risk Return Profile  
Volatility (Standard Deviation) 24.31% 69% C- 38% F
Risk Adjusted Return -1.01% 23% F 24% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector